Clinical Trial Update: Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach [NA]

View source ↗

Summary

A clinical trial update on an individualized, conventionally fractionated adaptive radiation therapy approach for bladder cancer, with the study currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Muscle-Invasive Bladder Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING